Literature DB >> 8751073

Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract.

J Latifpour1, Y Fukumoto, R M Weiss.   

Abstract

We investigated the binding characteristics of endothelin (ET) receptors in rabbit ureter, bladder dome, bladder base, and urethra and compared the observed receptor properties with those of cloned human ETA and ETB receptors expressed in Chinese hamster ovary K-1 (CHO) cells. Receptor binding experiments with [125I]ET-1 revealed the presence of a single class of specific, saturable, high affinity [125I]ET-1 binding sites in all of the regions of the studied urinary tract. The rank order of the densities (Bmax values) of [125I]ET-1 binding sites was: ureter "bladder dome > bladder base = urethra. ET-1 and ET-2 inhibited [125I]ET-1 binding to the membrane particulates from the various regions of the urinary tract with single high affinity constants. A selective ETA receptor antagonist, BQ 123, and selective ETB agonists, ET-3 and sarafotoxin S6c (STXc), inhibited [125I]ET-1 binding to bladder dome, bladder base, and urethra with high and low affinity constants indicating the presence of both ETA and ETB receptor subtypes in these tissues. The subtype specificity of ET receptors in the rabbit tissues is confirmed with inhibition data obtained from similar binding studies in cloned human ETA and ETB receptors. The proportions of high affinity binding sites for ET-3, representing ETB receptors, were approximately 25%, 27%, and 46% in bladder dome, bladder base, and urethra, respectively. Corresponding values for STXc were approximately 17%, 28%, and 43% in bladder dome, bladder base, and urethra, respectively. In contrast to the findings for ET-3 and STXc, the proportions of high affinity binding sites for BQ 123, representing ETA receptors, in bladder dome, bladder base, and urethra were approximately 84%, 74%, and 60%, respectively. In ureter, these selective compounds inhibited [125I]ET-1 binding with either a low (ET-3 and STXc) or a high binding affinity (BQ 123), suggesting the presence of only a single receptor subtype (ETA) in this tissue. These data indicate that there are regional differences in the density and subtype specificity of ET receptors in the rabbit urinary tract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8751073     DOI: 10.1007/bf00169378

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  58 in total

1.  Non-adrenergic, non-cholinergic nerve-mediated relaxation of rabbit urethra is caused by nitric oxide.

Authors:  K E Andersson; A Garcia Pascual; A Forman; A Tøttrup
Journal:  Acta Physiol Scand       Date:  1991-01

2.  Electrically-induced, nerve-mediated relaxation of rabbit urethra involves nitric oxide.

Authors:  K E Andersson; A Garcia Pascual; K Persson; A Forman; A Tøttrup
Journal:  J Urol       Date:  1992-01       Impact factor: 7.450

3.  Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells.

Authors:  I Komuro; H Kurihara; T Sugiyama; M Yoshizumi; F Takaku; Y Yazaki
Journal:  FEBS Lett       Date:  1988-10-10       Impact factor: 4.124

4.  Endothelin is a potent mitogen for rat vascular smooth muscle cells.

Authors:  Y Hirata; Y Takagi; Y Fukuda; F Marumo
Journal:  Atherosclerosis       Date:  1989-08       Impact factor: 5.162

5.  Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.

Authors:  J Latifpour; M Yoshida; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

6.  Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores.

Authors:  S Karne; C K Jayawickreme; M R Lerner
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

7.  Nitric oxide and relaxation of pig lower urinary tract.

Authors:  K Persson; K E Andersson
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes.

Authors:  D L Williams; K L Jones; D J Pettibone; E V Lis; B V Clineschmidt
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

9.  Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction.

Authors:  M L Webb; C C Chao; M Rizzo; R A Shapiro; M Neubauer; E C Liu; C R Aversa; R J Brittain; B Treiger
Journal:  Mol Pharmacol       Date:  1995-04       Impact factor: 4.436

10.  Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.

Authors:  P Nambi; M Pullen; W Spielman
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

View more
  5 in total

1.  Pharmacological characterization of endothelin receptor subtypes in the guinea-pig prostate gland.

Authors:  W A Lau; S L Cox; J N Pennefather; F J Mitchelson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Participation of endogenous endothelin and ETA receptor in premicturition contractions in rats with bladder outlet obstruction.

Authors:  Masashi Ukai; Hironori Yuyama; Yukiko Noguchi; Akiyoshi Someya; Hiroko Okutsu; Mai Watanabe; Taiji Yoshino; Akiyoshi Ohtake; Masanori Suzuki; Shuichi Sato; Masao Sasamata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-17       Impact factor: 3.000

3.  Developmental changes in the functional, biochemical and molecular properties of rat bladder endothelin receptors.

Authors:  Parviz Afiatpour; Jamshid Latifpour; Wataru Takahashi; Makoto Yono; Harris E Foster; Kazuyoshi Ikeda; Mehdi Pouresmail; Robert M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-17       Impact factor: 3.000

4.  Expression of endothelin receptor subtypes and their messenger RNAs in diabetic rat prostate: effect of insulin treatment.

Authors:  M Saito; Y Wada; K Ikeda; Z Wang; H E Foster; S D Smith; R M Weiss; J Latifpour
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

Review 5.  Neuropeptides in lower urinary tract function.

Authors:  Lauren Arms; Margaret A Vizzard
Journal:  Handb Exp Pharmacol       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.